AS-OCT useful for flap thickness measurement

Article

Anterior segment optical coherence tomography (AS-OCT) is a useful imaging tool for flap thickness measurement after femtosecond-assisted LASIK

Anterior segment optical coherence tomography (AS-OCT) is a useful imaging tool for flap thickness measurement after femtosecond-assisted LASIK, according to data published in Ophthalmic Surgery, Lasers and Imaging.

Dr Raciha Beril Kucumen et al., Department of Ophthalmology, Yeditepe University Medical Faculty, Istanbul, Turkey, prospectively studied 51 eyes of 26 patients suffering from myopia and myopic astigmatism. At 1 week preoperatively and 1 month postoperatively high resolution corneal images were observed.

The findings suggested that AS-OCT might not give accurate measurements in the central 2 mm area of the cornea. However, the measurements recorded at vertex and at 1 mm nasally were easily identified.

AS-OCT gives accurate high-resolution images enabling quantitative evaluaion of the flap-stroma relationship but precision is compromised in the central cornea. Overall, the researchers found that AS-OCT is a significantly useful imaging tool.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.